CollabRx(TM) and Projects In Knowledge(R) Partner to Provide Decision Support Tools to Oncologists

CollabRx(TM) and Projects In Knowledge(R) Partner to Provide Decision Support
Tools to Oncologists

SAN FRANCISCO, March 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX),
a data analytics company focused on informing clinical decision making in
molecular medicine, and Projects In Knowledge, Inc., a leading developer of
point-of-care digital and mobile information tools and continuing medical
education (CME/CE) programs, today announced a multi-year partnership
agreement to jointly distribute informational point-of-care software
applications to the more than 35,000 oncologists and other clinicians in the
Projects In Knowledge clinician network.

The partnership will focus initially on integrating CollabRx Therapy Finder™
products into the Projects In Knowledge @Point of Care360™ platform. Therapy
Finder applications are decision support tools that enable oncologists and
pathologists to take into account the genetics of a patient's tumor when
determining a treatment plan. The @Point of Care360 platform is a
next-generation interactive medical textbook that provides point-of-care
accessibility to educational resources and allows clinicians to access a
robust and easily searchable knowledge base.

"This partnership with CollabRx and use of its Therapy Finder products, which
we believe are 'best of breed', supports our goal to add tools at the point of
care that help the clinician in achieving positive patient outcomes," said
Robert Stern, CEO of Projects In Knowledge.

CollabRx and Projects In Knowledge will seek support from pharmaceutical and
biotechnology companies in the form of educational grants to conduct initial
activities of the partnership. Extension of the partnership scope and the
development of additional planned extensions of the integrated offering will
be commercialized using other mechanisms.

"We are honored to be working with Projects In Knowledge to help oncologists
deliver the best possible care to their patients," said Thomas Mika, President
& CEO of CollabRx. "This agreement represents a significant milestone by
CollabRx in facilitating access to its Therapy Finder product line by large
numbers of practicing physicians to inform cancer treatment planning at the
point of care."

About CollabRx

CollabRx, Inc. (Nasdaq:CLRX) is a recognized leader in cloud-based expert
systems to inform healthcare decision-making. CollabRx uses information
technology to aggregate and contextualize the world's knowledge on
genomics-based medicine with specific insights from the nation's top cancer
experts, starting with the area of greatest need: advanced cancers in patients
who have effectively exhausted the standard of care. More information may be
obtained at

The CollabRx, Inc. logo is available at

About Projects In Knowledge

Projects In Knowledge is a fully accredited provider of cutting-edge
educational programs for physicians and other clinicians. Since 1980, our
mission has been to improve the quality of healthcare in the United States and
abroad by delivering exceptional professional education, with demonstrated
results, using creative, effective, and easily accessible instructional
modalities. Learn more about us and view our CME/CE programs at

CollabRx Safe Harbor Statement

This press release includes forward-looking statements about CollabRx's
anticipated results that involve risks and uncertainties. Some of the
information contained in this press release, including, but not limited to,
statements as to industry trends and CollabRx's plans, objectives,
expectations and strategy for its business, contains forward-looking
statements that are subject to risks and uncertainties that could cause actual
results or events to differ materially from those expressed or implied by such
forward-looking statements. Any statements that are not statements of
historical fact are forward-looking statements. When used, the words
"believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and
the like, and/or future tense or conditional constructions ("will," "may,"
"could," "should," etc.), or similar expressions, identify certain of these
forward-looking statements. Important factors that could cause actual results
to differ materially from those in the forward-looking statements are detailed
in filings made by CollabRx with the Securities and Exchange Commission.
CollabRx undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.

CONTACT: CollabRx Contacts:
         Thomas R. Mika, CEO
         CollabRx, Inc.
         (415) 248-5350
         Robert Ferri Partners, LLC
         Robert Ferri
         (415) 575-1589 (direct)
         Projects In Knowledge Contact:
         Patty Peterson, CCMEP
         Senior Vice President
         Projects In Knowledge, Inc.
         (973) 200-2523

CollabRx, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.